Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | PRKCA | P17252 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17822545 | 0.82 | CA1 (0.43) | CA1CA9CYP1A2PRKCA | |
| SCHEMBL19388490 | 0.82 | CA1 (0.43) | CA1CA9CYP1A2PRKCA | |
| SCHEMBL19919867 | 0.82 | CA1 (0.43) | CA1CA9CYP1A2PRKCA | |
| SCHEMBL8556521 | 0.82 | CA1 (0.39) | CA1CA9CYP1A2PRKCA | |
| SCHEMBL9464860 | 0.82 | CA1 (0.39) | CA1CA9CYP1A2PRKCA | |
| SCHEMBL19388489 | 0.79 | CYP1A2 (0.42) | CA1CA9CYP1A2PRKCA | |
| SCHEMBL5004697 | 0.78 | — | — | |
| SCHEMBL7963430 | 0.78 | — | — | |
| SCHEMBL17831604 | 0.78 | — | — | |
| SCHEMBL27920507 | 0.78 | CA1 (0.46) | CA1CA9CYP1A2PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2643326-B1 | Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro[2,3-b]furan-3-ol | MYLAN LAB LTD (IN) | 2016-09-14 | — | — | EP | disclosed |
| US-8841467-B2 | Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol | MYLAN LABORATORIES LIMITED (IN) | 2014-09-23 | — | — | US | disclosed |
| EP-2643326-A1 | PROCESS FOR THE PREPARATION OF (3R, 3AS, 6AR)-HEXAHYDROFURO [2, 3- B]FURAN-3-OL | Mylan Laboratories, Limited (IN) | 2013-10-02 | — | — | EP | disclosed |
| US-20130244297-A1 | PROCESS FOR THE PREPARATION OF (3R, 3AS, 6AR)-HEXAHYDROFURO [2, 3- B] FURAN-3-OL | Mylan Laboratories Ltd. (IN) | 2013-09-19 | — | — | US | disclosed |
| WO-2012070057-A1 | PROCESS FOR THE PREPARATION OF (3R, 3AS, 6AR)-HEXAHYDROFURO [2, 3- B] FURAN-3-OL | MATRIX LABORATORIES LTD (IN) | 2012-05-31 | — | — | WO | disclosed |
| WO-2008034598-A1 | METHOD FOR THE SYNTHESIS OF HEXAHYDROFURO (2, 3-B) FURAN-3-OL COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2008-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130244297-A1 | PROCESS FOR THE PREPARATION OF (3R, 3AS, 6AR)-HEXAHYDROFURO [2, 3- B] FURAN-3-OL | HPD, HAAO, DHRS9 | CA1 2054/4885CA9 1796/4885CYP1A2 249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.